Valeant Completes Acquisition Of Natur Produkt In Russia
MONTREAL , Feb. 1, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced the completion of its acquisition of Natur Produkt International, JSC, a specialty pharmaceutical company in Russia , for approximately $163 million , plus adjustments for net debt and working capital. Natur Produkt has a significant presence in the over-the-counter (OTC) segment in several categories marketed under the umbrella brand, Natur Produkt. Key brands include AntiGrippin, a leading cough and cold remedy, Anti Angin, Sage and Eucaplyptus MA brand names, leading sore throat remedies.
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.
Contact Information:
Laurie W. Little
949-461-6002
[email protected]
(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)
SOURCE: Valeant Pharmaceuticals International, Inc.
Contact:
http://www.valeant.com
http://photos.prnewswire.com/prnh/20101025/LA87217LOGO